Gilead Sciences
Utility Patent Applications
Last updated:
List of all Gilead Sciences patents 176 in total
| Status | Patent |
|---|---|
Application | Utility: TETRACYCLIC COMPOUNDS AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ANTIVIRAL COMPOUNDS Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ANTIVIRAL COMPOUNDS Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: METHODS FOR TREATING SARS COV-2 INFECTIONS Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: 4,6-DI- AND 2,4,6-TRISUBSTITUTED QUINAZOLINE DERIVATIVES USEFUL FOR TREATING VIRAL INFECTIONS Filling date: 5 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: 2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: PYRROLO[1,2-b]PYRIDAZINE DERIVATIVES Filling date: 5 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: CAPSID INHIBITORS FOR THE PREVENTION OF HIV Filling date: 5 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS Filling date: 5 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: TRIAZOLE CARBAMATE PYRIDYL SULFONAMIDES AS LPA RECEPTOR ANTAGONISTS AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: MCL1 INHIBITORS Filling date: 5 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: GLP-1R MODULATING COMPOUNDS Filling date: 5 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS Filling date: 5 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: CRYSTALLINE FORMS OF (S)-2-ETHYLBUTYL 2-(((S)-(((2R,3S,4R,5R)-5- (4-AMINOPYRROLO[2,1-F] [1,2,4]TRIAZIN-7-YL)-5-CYANO-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHOXY) (PHENOXY) PHOSPHORYL)AMINO)PROPANOATE Filling date: 5 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES Filling date: 5 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: TLR-9 AGONISTS FOR MODULATION OF TUMOR MICROENVIRONMENT Filling date: 5 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: COT MODULATORS AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ANTIBODIES AND FRAGMENTS THEREOF THAT BIND HEPATITIS B VIRUS PROTEIN X Filling date: 5 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS Filling date: 5 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: HBV VACCINES AND METHODS TREATING HBV Filling date: 5 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: HIV PROTEASE INHIBITORS Filling date: 5 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS Filling date: 5 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: FLT3L-Fc FUSION PROTEINS AND METHODS OF USE Filling date: 5 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: COT MODULATORS AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS Filling date: 5 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN Filling date: 5 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: THIENOPYRIMIDINE DERIVATIVES AS ACC INHIBITORS AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS Filling date: 5 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: PD-1/PD-L1 INHIBITORS Filling date: 5 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS Filling date: 5 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Filling date: 5 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: PROCESSES FOR PREPARING ACC INHIBITORS AND SOLID FORMS THEREOF Filling date: 5 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: PD-1/PD-L1 INHIBITORS Filling date: 5 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: HIV VACCINES AND METHODS OF MAKING AND USING Filling date: 5 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS Filling date: 5 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE Filling date: 5 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: METHODS OF TREATING LIVER DISEASE Filling date: 5 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: FLT3L-Fc FUSION PROTEINS AND METHODS OF USE Filling date: 5 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS Filling date: 5 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Choline Salt Forms of an HIV Capsid Inhibitor Filling date: 5 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: COT MODULATORS AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: SUBSTITUTED ENEOXINDOLES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13- ,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPINE-1- 0-CARBOXAMIDE Filling date: 5 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: MULTISPECIFIC ANTIBODIES THAT TARGET HIV GP120 AND CD3 Filling date: 5 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: METHODS OF TREATING FELINE CORONAVIRUS INFECTIONS Filling date: 5 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: FXR (NR1H4) MODULATING COMPOUNDS Filling date: 5 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH GP120 V3 GLYCAN-DIRECTED ANTIBODIES Filling date: 5 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS Filling date: 5 Sep 2025 Issue date: 26 Nov 2020 |
Showing 50 to 100 of 176 patents.